Biofrontera (BFRIW) Change in Accured Expenses (2020 - 2025)

Biofrontera's Change in Accured Expenses history runs 6 years deep, the most recent figure standing at -$1.7 million for Q4 2025.

• In Q4 2025, Change in Accured Expenses fell 321.32% year-over-year to -$1.7 million; the TTM figure through Dec 2025 stood at $610000.0 (up 365.22% YoY), while the FY2025 annual figure was $610000.0, up 365.22% from the prior year.
• Change in Accured Expenses was -$1.7 million for Q4 2025 at Biofrontera, down from $746000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.2 million in Q3 2023 to a low of -$12.5 million in Q4 2023.
• Historically, Change in Accured Expenses has averaged -$291600.0 across 5 years, with a median of $57500.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses soared 4114.63% in 2022, then plunged 379.02% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at -$1.1 million in 2021, then tumbled by 141.17% to -$2.6 million in 2022, then plunged by 379.02% to -$12.5 million in 2023, then soared by 96.84% to -$394000.0 in 2024, then sank by 321.32% to -$1.7 million in 2025.
• The last three Change in Accured Expenses figures came in at -$1.7 million (Q4 2025), $746000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.